BioXcel Therapeutics, Inc. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001558370-25-011158
- Form type
- 10-Q
- CIK
- 0001720893
- Primary document
- https://www.sec.gov/Archives/edgar/data/1720893/000155837025011158/btai-20250630x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioXcel Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $288,000 | - | - |
| Cost Of Revenue | $121,000 | - | - |
| Operating Income | $-26.0M | - | - |
| Net Income | $-26.4M | - | - |
| Eps Basic | -4.17 | - | - |
| Eps Diluted | -4.17 | - | - |
| Cash And Equivalents | $17.4M | - | - |
| Total Assets | $25.8M | - | - |
| Total Liabilities | $133.5M | - | - |
| Shareholders Equity | $-107.7M | - | - |
| Operating Cash Flow | $-24.6M | - | - |
| Capital Expenditures | $0 | - | - |